Pharmacological treatment of ischemic cerebrovascular disease To early thrombolytic therapy to restore blood oxygen supply. To improve cerebral circulation, reduce cerebral metabolism, and reduce cerebral edema. Systemic therapeutic drugs to correct hyperglycemia, reduce blood viscosity, and maintain water-electrolyte balance. To prevent the recurrence of cerebral embolism, stabilize the patient’s condition, organize the further development of cerebral infarction, reduce neurological deficits as much as possible, and prevent the occurrence of complications. Drug therapy 1. Treatment mechanism: thrombolysis, antithrombolysis, fibrin-lowering; 2. Selection of therapeutic drugs; ultra-early (within 6h of onset) thrombolytic therapy is used, ① commonly used drugs are alteplase, ② must be used within 3h of onset ③ Precautions: thrombolytic therapy should be given simultaneously with gastric mucosal protective agent; low-molecular dextrose or 20% mannitol injection can be administered intravenously before thrombolysis; monitor the blood pressure changes before, during and after treatment The bleeding usually occurs after thrombolysis. Acute phase (within 48h of onset): ①Application of hemodilution therapy, commonly used drugs are low molecular dextrose cataracts. ②Anticoagulation therapy, commonly used heparin, indications for heparin anticoagulation therapy: transient ischemic attack, cerebral thrombosis and cerebral embolism, especially the transient ischemic attack has the best effect. ③Anti-platelet aggregation drugs, commonly used low-dose aspirin, can both prevent and treat cerebral ischemia and avoid adverse reactions. ④Vasodilators commonly used drugs include ginkgo biloba preparations, which have good therapeutic effect on ischemic cerebrovascular disease. ⑤ Dehydration drugs 20% mannitol injection can reduce cerebral edema has a certain effect on reducing infarct area and preventing disability. ⑥Commonly used calcium channel blockers include nimodipine, nicardipine and verapamil. (6) Use brain metabolic activators such as cytarabine cataracts collected by Education.com. Recovery period: Oral vitamins E and C, antioxidants such as ginkgo biloba preparations, herbal preparations to activate blood circulation and remove blood stasis, and low-dose aspirin can be taken to achieve the purpose of recovery treatment.